Researchers compared two groups of women with morbid obesity: nearly 18,000 who underwent various forms of so-called bariatric surgery and nearly 54,000 who did not. The groups were similar in terms of age, medical conditions and body mass index (BMI, a ratio of weight to height).
Researchers tracked the surgery group for an average of about 48 months and the no-surgery group for an average of about 41 months. During the study period, women who had the weight-loss operations had a 37 per cent lower risk of developing breast cancer compared to women who didn’t, the researchers reported in Annals of Surgery.
The risk was lowered by 45 per cent in postmenopausal women and by 28 per cent in premenopausal women.
Among postmenopausal women, the reduction in risk was more pronounced for estrogen receptor (ER)-positive cancers. These tumours depend on the hormone estrogen for growth; the estrogen attaches to proteins called receptors on the cancer cells.
Among premenopausal women, by contrast, the risk reduction was more pronounced for ER-negative cancers, which don’t depend on estrogen to grow and are more common in younger women.
“The main takeaway is that the benefits are not exclusive to postmenopausal women or ER-positive women and this adds to the now growing body of literature supporting cancer reduction as a meaningful benefit of weight loss,” Dr Brian Smith of UC Irvine Health in Orange, California, who was not involved in the study.
The most common bariatric procedure in the current study was Roux-en-Y gastric bypass, which reduces the stomach to about the size of an egg and rearranges the intestine so that food bypasses part of it. Next most common was sleeve gastrectomy, which reduces the stomach to the size of a banana.
According to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases, the benefits of weight loss surgery can also include improvements in many health problems related to obesity, such as type 2 diabetes, high blood pressure, high cholesterol, sleep apnoea, urinary incontinence, and knee and hip pain.
The researchers on the current study found, however, that the reduction in breast cancer risk began to evaporate beginning about three years after the operations were performed, possibly as people tend to regain their weight.
Further studies will need to observe the patients for longer periods and consider the amount of weight lost and regained to see if the benefit of cancer risk reduction can be maintained, said study leader Heather Spencer Feigelson of the Kaiser Permanente Institute for Health Research in Aurora, Colorado.
“It could just be that this effect we’re seeing is only a short-term effect,” she said.
Source: Reuters Health